No connection

Search Results

BLW vs HQL

BLW
BlackRock Limited Duration Income Trust
BEARISH
Price
$13.77
Market Cap
$533.4M
Sector
Financial Services
AI Confidence
68%
HQL
Abrdn Life Sciences Investors
BULLISH
Price
$17.56
Market Cap
$534.0M
Sector
Financial Services
AI Confidence
75%

Valuation

P/E Ratio
BLW
9.91
HQL
6.29
Forward P/E
BLW
--
HQL
--
P/B Ratio
BLW
0.98
HQL
1.01
P/S Ratio
BLW
8.52
HQL
275.47
EV/EBITDA
BLW
--
HQL
--

Profitability

Gross Margin
BLW
100.0%
HQL
100.0%
Operating Margin
BLW
91.48%
HQL
-346.83%
Profit Margin
BLW
81.91%
HQL
4415.74%
ROE
BLW
9.88%
HQL
17.59%
ROA
BLW
4.0%
HQL
-0.43%

Growth

Revenue Growth
BLW
-3.4%
HQL
-69.9%
Earnings Growth
BLW
26.0%
HQL
259.4%

Financial Health

Debt/Equity
BLW
0.62
HQL
--
Current Ratio
BLW
0.07
HQL
0.73
Quick Ratio
BLW
0.06
HQL
0.71

Dividends

Dividend Yield
BLW
9.86%
HQL
12.76%
Payout Ratio
BLW
97.73%
HQL
65.23%

AI Verdict

BLW BEARISH

The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a high dividend yield of 9.86%, the payout ratio is alarmingly high at 97.73%, threatening sustainability. Profitability metrics are strong on paper with a 91.48% operating margin and 81.91% profit margin, but these are offset by weak liquidity (Current Ratio: 0.07) and negative revenue growth. The stock trades below its Graham Number of $20.91 and intrinsic value estimate of $41.0, suggesting potential undervaluation, but structural risks and poor technical trend (0/100) undermine this advantage.

Strengths
High profitability with operating margin of 91.48% and net margin of 81.91%
Low P/E ratio of 9.91 compared to sector average of 30.45, indicating potential undervaluation
Strong ROE of 9.88% in a sector where average ROE is negative (-9.78%)
Risks
Extremely weak liquidity with Current Ratio of 0.07 and Quick Ratio of 0.06, indicating near-term solvency concerns
Revenue declining YoY by -3.40%, suggesting underlying business contraction
Payout ratio of 97.73% jeopardizes dividend sustainability
HQL BULLISH

HQL presents as a deep-value opportunity, anchored by a stable Piotroski F-Score of 6/9 and a significant valuation gap, with a current price of $17.56 trading well below its Graham Number ($33.01) and Intrinsic Value ($82.31). While the company exhibits severe operational anomalies—specifically a -69.90% revenue collapse and a deeply negative operating margin—the massive earnings growth and low P/E ratio (6.29) suggest the entity is benefiting from significant investment gains rather than core fee income. The high dividend yield of 12.76% is supported by a sustainable payout ratio, though the bearish technical trend (10/100) suggests a period of consolidation or price correction is underway.

Strengths
Extreme undervaluation relative to Graham Number ($33.01) and Intrinsic Value ($82.31)
Very low P/E ratio (6.29) compared to the sector average of 36.83
Strong dividend yield of 12.76% with a manageable payout ratio (65.23%)
Risks
Severe revenue decline (-69.90% YoY) indicating a collapse in core business growth
Poor operational efficiency with an operating margin of -346.83%
Liquidity risk evidenced by a current ratio of 0.73 (below 1.0)

Compare Another Pair

BLW vs HQL: Head-to-Head Comparison

This page compares BlackRock Limited Duration Income Trust (BLW) and Abrdn Life Sciences Investors (HQL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile